EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants

Hyungji Jang iD, Juyoung Khwarg iD, Ki Young Huh iD, Dong-Min Park iD, Heejung Park iD, Kyung-Sang Yu iD

Translational and Clinical Pharmacology · 2026 · 34 (2) · 116

DOI: 10.12793/tcp.2026.34.e8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2026. Verfasst von Hyungji Jang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080,…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yuhan Corporation, Addpharma Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cross-Over StudiesDyslipidemiasHydroxymethylglutaryl-CoA Reductase InhibitorsPharmacokineticsRandomized Controlled Trial

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Yuhan R&D Institute, Yuhan Corporation, Yongin 17084, Korea.

ORCID-Profile: Hyungji Jang, Juyoung Khwarg, Ki Young Huh, Dong-Min Park, Heejung Park, Kyung-Sang Yu

Förderung

  • Yuhan Corporation
  • Addpharma Co., Ltd.

Zitieren

APA

Jang, H., Khwarg, J., Huh, K. Y., Park, D. M., Park, H., & Yu, K. S. (2026). Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. Translational and Clinical Pharmacology, 34(2), 116. https://doi.org/10.12793/tcp.2026.34.e8

Vancouver

Jang H, Khwarg J, Huh KY, Park DM, Park H, Yu KS. Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants. Translational and Clinical Pharmacology. 2026;34(2):116. doi:10.12793/tcp.2026.34.e8

BibTeX
@article{Jang2026,
  author = {Jang, Hyungji and Khwarg, Juyoung and Huh, Ki Young and Park, Dong-Min and Park, Heejung and Yu, Kyung-Sang},
  title = {Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants},
  journal = {Translational and Clinical Pharmacology},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {116},
  doi = {10.12793/tcp.2026.34.e8}
}
Kostenlos starten →